# Avalyn Pharma IPO (AVLN): price, date and first-day trading

> Avalyn Pharma (AVLN) priced its IPO at $18.00 a share and has traded on Nasdaq since Apr 30, 2026.

Canonical: https://massive.com/quote/avln/ipo
Data as of: 2026-11-18T21:20:48.030Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## AVLN price

| Figure | Value |
| --- | --- |
| Price | $28.09 |
| Change from the IPO price | +56.06% |
| Change today | +0.61% |

## How AVLN did against the market

AVLN against the market, from its first trade at 12:20 ET to the last trade of the session.

| Measure | Value |
| --- | --- |
| AVLN from its first trade | +13.46% |
| Against the market (QQQ) | +12.9 pts |

## The IPO scoreboard

AVLN against other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

| IPO | Raised | First trade | Day 1 close | Day 5 | Day 30 |
| --- | --- | --- | --- | --- | --- |
| Avalyn Pharma | $300M | +44.44% | +63.89% | +51.39% | +56.50% |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |

## The offering

| Term | Value |
| --- | --- |
| Expected price range | $16 to $18 |
| IPO price | $18.00 |
| Shares offered | 16.67M |
| Money raised | $300M |
| Listing date | Apr 30, 2026 |
| Exchange | Nasdaq |
| Security | Ordinary Shares |

## Where AVLN ranks

The company's market cap against the largest US-listed companies.

| Company | Market cap |
| --- | --- |
| AAPL | $5.12T |
| MSFT | $3.77T |
| NVDA | $3.65T |
| GOOGL | $3.47T |
| AMZN | $2.9T |
| TSM | $1.88T |
| AVGO | $1.69T |
| META | $1.58T |
| TSLA | $1.52T |
| BRK.B | $1.22T |
| AVLN | $1.23B |

## Insider buying and selling after the IPO

From Sep 17, 2026 to Nov 19, 2026, one AVLN insider reported open-market sales of $6.7M across 1 filing; no open-market purchases were filed.

- FMR LLC, 10% owner: sold $6.7M, filed Nov 12, 2026

Sales made in the offering itself are left out.

[Who traded and when](https://massive.com/quote/avln/insider-trading.md)

## AVLN news

- [Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026](https://www.globenewswire.com/news-release/2026/08/24/3350091/0/en/avalyn-announces-multiple-presentations-at-the-european-respiratory-society-international-congress-2026.html) · GlobeNewswire Inc. · Aug 24, 2026
- [Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis](https://www.globenewswire.com/news-release/2026/06/17/3313361/0/en/Avalyn-Completes-Target-Enrollment-in-Phase-2b-MIST-Trial-of-AP01-Inhaled-Pirfenidone-for-Patients-with-Progressive-Pulmonary-Fibrosis.html) · GlobeNewswire Inc. · Jun 17, 2026
- [Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights](https://www.globenewswire.com/news-release/2026/06/03/3305895/0/en/Avalyn-Reports-First-Quarter-2026-Financial-Results-and-Recent-Business-Highlights.html) · GlobeNewswire Inc. · Jun 3, 2026

## Filings and the company

Material events that Avalyn Pharma has disclosed to the SEC on Form 8-K.

- Nov 12, 2026 · Quarterly earnings ([filing](https://www.sec.gov/Archives/edgar/data/1540171/0001193125-26-457053.txt))
- Sep 16, 2026 · Executive compensation change ([filing](https://www.sec.gov/Archives/edgar/data/1540171/0001193125-26-393081.txt))
- Jul 1, 2026 · Lease agreement ([filing](https://www.sec.gov/Archives/edgar/data/1540171/0001193125-26-292834.txt))
- May 1, 2026 · Charter amendment ([filing](https://www.sec.gov/Archives/edgar/data/1540171/0001193125-26-201434.txt))

## FAQ

### What was the Avalyn Pharma IPO price?

$18.00 a share.

### When did Avalyn Pharma go public?

Avalyn Pharma listed on Nasdaq on Apr 30, 2026 under the ticker AVLN.

### How much did the Avalyn Pharma IPO raise?

$300M, before any underwriters' option.

### How did Avalyn Pharma open on its first day?

AVLN first traded at $26.00, +44.44% from the IPO price of $18.00.

### How did AVLN close on its first day?

Its last regular-session trade was $29.50, +63.89% from the IPO price of $18.00.

### What was the AVLN first-day trading range?

$26.00 to $30.20 in the regular session.

### How many AVLN shares traded on the first day?

6.31M shares in the regular session.

### How many shares did Avalyn Pharma sell in its IPO?

16.67M shares.

### How did AVLN do against the market on its first day?

AVLN rose 13.5% from its first trade to the last trade of the session. That is 12.9 points better than the market (QQQ, the Nasdaq-100 ETF).

### What exchange is AVLN listed on?

Avalyn Pharma lists on Nasdaq under the ticker AVLN.

## Live data

The IPO record and the price come from the Massive API.

- `GET https://api.massive.com/vX/reference/ipos?ticker=AVLN`
- `GET https://api.massive.com/v3/snapshot?ticker.any_of=AVLN`
- `GET https://api.massive.com/v2/aggs/ticker/AVLN/range/5/minute/{date}/{date}`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Markets overview](https://massive.com/quote/index.md)
- [Insider trading](https://massive.com/quote/insider-trading.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
